Moritz Binder

100PUBLICATIONS
220CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (100)

|Aug 20, 2026
Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas.

|Aug 03, 2026
High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

|Jul 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

|Jul 27, 2026
Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective Study.

|Jul 21, 2026
Cytogenetics-based clinical trajectories in patients with MRD negativity post autologous transplant for multiple myeloma.

|Jul 18, 2026
Combination of daratumumab, ixazomib, and lenalidomide with or without dexamethasone for initial therapy of newly diagnosed myeloma.

Pageof 17

Frequent Collaborators

68 joint publications

Shaji Kumar

62 joint publications

Taxiarchis V Kourelis

58 joint publications

Angela Dispenzieri

56 joint publications

Morie Gertz